[144] Esperion Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Esperion Therapeutics (ESPR) report of proposed sale under Rule 144: An individual plans to sell 28,427 common shares through Fidelity Brokerage Services on 09/17/2025, with an aggregate market value of $79,240.27. The shares were acquired on 09/15/2025 via restricted stock vesting and payment was for compensation. The filing lists 201,622,825 shares outstanding, so the proposed sale represents a very small fraction of total shares. The filer also reported a prior sale of 30,474 shares on 06/17/2025 generating $33,792.63. The filing includes the seller's representation regarding material nonpublic information.

Positive

• Transaction disclosed clearly: acquisition date, nature (restricted stock vesting), broker, sale date, and dollar value are provided
• Sale size is immaterial: 28,427 shares represent a very small fraction of 201,622,825 shares outstanding

Negative

• Filer identification fields (CIK and contact details) are not present in the provided content
• Signature and notice date are not shown in the provided text, so filing completeness cannot be verified here

Insights

Securities Analyst

TL;DR Proposed sale is immaterial to ESPR supply and appears to be routine insider vesting and disposition.

The transaction shows a grant vesting followed by an intended sale of 28,427 shares valued at $79,240.27, executed through a major broker. Relative to the 201.6 million shares outstanding, this is immaterial and unlikely to influence market valuation. The filer disclosed a similar sale of 30,474 shares in June 2025, indicating ongoing conversion of compensation equity to cash. From a market-impact perspective, these amounts are routine for compensated insiders and should not materially affect liquidity or share price.

Compliance / Corporate Governance Expert

TL;DR Filing documents a standard Rule 144 notice but omits several identifying filer fields visible in the form.

The form identifies the broker, acquisition method (restricted stock vesting), acquisition and planned sale dates, and past sales, and contains the required representation about nonpublic information. However, key filer identification fields (CIK, filer contact name and email) appear blank in the provided content, and the form's signature block details are not shown. For compliance review, confirm the filing includes a signed notice and complete filer identifiers in the official EDGAR submission to ensure regulatory completeness.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	28427	79240.27	201622825	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2025	Restricted Stock Vesting	Issuer			28427	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Sheldon Koenig 3891 Ranchero Drive Suite 150 Ann Arbor MI 48108	Common	06/17/2025	30474	33792.63

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of ESPR are proposed to be sold under this Form 144?

The notice reports a proposed sale of 28,427 common shares on 09/17/2025 through Fidelity Brokerage Services.

How much are the proposed 28,427 ESPR shares valued at?

The aggregate market value is stated as $79,240.27.

How were the shares acquired that are being sold?

The shares were acquired on 09/15/2025 by restricted stock vesting and payment is listed as compensation.

Has the filer sold ESPR shares recently?

Yes, the filing reports a prior sale of 30,474 common shares on 06/17/2025 with gross proceeds of $33,792.63.

Is this sale material to ESPR's outstanding shares?

No. The company has 201,622,825 shares outstanding, so the proposed sale is a very small portion of total shares.